Found: 27
Select item for more details and to access through your institution.
Dramatic response of STRN-NTRK-fused malignant glioneuronal tumor to larotrectinib in adult.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1200, doi. 10.1093/neuonc/noab080
- By:
- Publication type:
- Article
Prognostic factors in leptomeningeal metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1208, doi. 10.1093/neuonc/noab051
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1212, doi. 10.1093/neuonc/noz018
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1211, doi. 10.1093/neuonc/noy203
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1210, doi. 10.1093/neuonc/noy179
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1052, doi. 10.1093/neuonc/noab117
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1213, doi. 10.1093/neuonc/noab116
- Publication type:
- Article
Adjuvant therapy for high-risk medulloblastoma: more is better?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1048, doi. 10.1093/neuonc/noab104
- By:
- Publication type:
- Article
Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1041, doi. 10.1093/neuonc/noab099
- By:
- Publication type:
- Article
Lepto mets: loads of data.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1044, doi. 10.1093/neuonc/noab089
- By:
- Publication type:
- Article
Beyond the brain: socioeconomic status and race in pediatric brain tumor survivorship.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1050, doi. 10.1093/neuonc/noab079
- By:
- Publication type:
- Article
Reply to D'Alessandris et al.: Clear evidence of differences between tumor-resident mesenchymal stemlike cells and bone marrow-derived mesenchymal stem cells.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1205, doi. 10.1093/neuonc/noab068
- By:
- Publication type:
- Article
Pediatric spinal cord gliomas—low grade but high risk for recurrence: should we treat them differently from intracranial low-grade gliomas?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1046, doi. 10.1093/neuonc/noab062
- By:
- Publication type:
- Article
Validation of the prognostic value of 9-gene ATE score for IDH wild-type glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1197, doi. 10.1093/neuonc/noab058
- By:
- Publication type:
- Article
The relevance of surgical status in nodular leptomeningeal metastasis patient outcomes.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1207, doi. 10.1093/neuonc/noab035
- By:
- Publication type:
- Article
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1056, doi. 10.1093/neuonc/noab020
- By:
- Publication type:
- Article
Mesenchymal stem cells: are they the good or the bad?
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1203, doi. 10.1093/neuonc/noab024
- By:
- Publication type:
- Article
OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1183, doi. 10.1093/neuonc/noab016
- By:
- Publication type:
- Article
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1139, doi. 10.1093/neuonc/noab019
- By:
- Publication type:
- Article
The impact of socioeconomic status (SES) on cognitive outcomes following radiotherapy for pediatric brain tumors: a prospective, longitudinal trial.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1173, doi. 10.1093/neuonc/noab018
- By:
- Publication type:
- Article
Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1087, doi. 10.1093/neuonc/noab012
- By:
- Publication type:
- Article
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1125, doi. 10.1093/neuonc/noab011
- By:
- Publication type:
- Article
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1072, doi. 10.1093/neuonc/noab001
- By:
- Publication type:
- Article
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1163, doi. 10.1093/neuonc/noaa301
- By:
- Publication type:
- Article
Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1100, doi. 10.1093/neuonc/noaa298
- By:
- Publication type:
- Article
High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1148, doi. 10.1093/neuonc/noaa296
- By:
- Publication type:
- Article
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 7, p. 1113, doi. 10.1093/neuonc/noaa284
- By:
- Publication type:
- Article